Follow
Rudo Simeon
Rudo Simeon
Verified email at tamu.edu
Title
Cited by
Cited by
Year
In vitro-engineered non-antibody protein therapeutics
R Simeon, Z Chen
Protein Cell 9 (1), 3-14, 2018
1852018
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
K Chockalingam, RL Simeon, CM Rice, Z Chen
Proceedings of the National Academy of Sciences 107 (8), 3764-3769, 2010
902010
Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes
AM Chamoun-Emanuelli, EI Pecheur, RL Simeon, D Huang, PS Cremer, ...
Antimicrobial agents and chemotherapy 57 (6), 2571-2581, 2013
612013
PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus
AM Chamoun, K Chockalingam, M Bobardt, R Simeon, J Chang, P Gallay, ...
Antimicrobial agents and chemotherapy 56 (2), 672-681, 2012
442012
Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B
R Simeon, M Jiang, AM Chamoun-Emanuelli, H Yu, Y Zhang, R Meng, ...
PLoS biology 17 (6), e3000311, 2019
312019
Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027
Z Peng, R Simeon, SB Mitchell, J Zhang, H Feng, Z Chen
mSphere 4 (5), e00596-19, 2019
172019
Discovery and characterization of a new cell-penetrating protein
RL Simeon, AM Chamoun, T McMillin, Z Chen
ACS chemical biology 8 (12), 2678-2687, 2013
142013
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins
V Chonira, YD Kwon, J Gorman, JB Case, Z Ku, R Simeon, RG Casner, ...
Nature Chemical Biology, 1-8, 2022
122022
Creation and characterization of a cell-death reporter cell line for hepatitis C virus infection
Z Chen, RL Simeon, K Chockalingam, CM Rice
Antiviral research 86 (2), 220-223, 2010
102010
Structural dynamics of receptor recognition and pH-induced dissociation of full-length Clostridioides difficile Toxin B
M Jiang, J Shin, R Simeon, JY Chang, R Meng, Y Wang, O Shinde, P Li, ...
PLoS Biology 20 (3), e3001589, 2022
92022
Protease-stable DARPins as promising oral therapeutics
RA Simeon, Y Zeng, V Chonira, AM Aguirre, M Lasagna, M Baloh, ...
Protein Engineering, Design and Selection 34, 2021
32021
A Multi-Specific DARPin Potently Neutralizes Shiga Toxin 2 via Simultaneous Modulation of Both Toxin Subunits
Y Zeng, M Jiang, S Robinson, Z Peng, V Chonira, R Simeon, S Tzipori, ...
Bioengineering 9 (10), 511, 2022
22022
A Screen for Genetic Suppressor Elements of Hepatitis C Virus Identifies a Supercharged Protein Inhibitor of Viral Replication
RL Simeon, Z Chen
PloS one 8 (12), e84022, 2013
22013
De Novo Isolation & Affinity Maturation of yeast-displayed Virion-binding human fibronectin domains by flow cytometric screening against Virions
P Heinzelman, A Low, R Simeon, GA Wright, Z Chen
Journal of biological engineering 13 (1), 76, 2019
12019
Protein inhibitors of clostridium difficile toxin b
Z Chen, R Simeon, AM Chamoun-Emanuelli, P Zeyu, H Feng, H Yu, ...
US Patent App. 17/609,818, 2022
2022
Virucidal small molecule and uses thereof
Z Chen, K Chockalingam, AM Chamoun-Emanuelli, R Simeon, M Bobardt, ...
US Patent App. 14/023,437, 2014
2014
Virucidal small molecule and uses thereof
Z Chen, K Chockalingam, AM Chamoun-Emanuelli, R Simeon, M Bobardt, ...
US Patent App. 14/023,434, 2014
2014
Selecting a path against Hepatitis C Virus
RL Simeon
2013
PD 404,182 as an HIV microbicide candidate
AM Chamoun-Emanuelli, K Chockalingam, M Bobardt, R Simeon, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013
2013
B1 mediated protein transfection
RL Simeon, AM Chamoun, TC McMillan, Z Chen
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20